Publicacións nas que colabora con Jesús Martínez Beltrán (11)

2008

  1. Etiología de la infección urinaria baja adquirida en la comunidad y resistencia de Escherichia coli a los antimicrobianos de primera línea. Estudio nacional multicéntrico

    Medicina Clinica, Vol. 130, Núm. 13, pp. 481-486

2006

  1. Erratum: OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain (Antimicrobial Agents and Chemotherapy [2000] 44, 6 [1556-1561])

    Antimicrobial Agents and Chemotherapy

2005

  1. Cloning and functional analysis of the gene encoding the 33- to 36-kilodalton outer membrane protein associated with carbapenem resistance in Acinetobacter baumannii

    Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 12, pp. 5172-5175

2004

  1. Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals

    Infection Control and Hospital Epidemiology, Vol. 25, Núm. 10, pp. 819-824

2000

  1. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: High-level carbapenem resistance in A. baumannii is not due solely to the presence of β-lactamases

    Journal of Clinical Microbiology, Vol. 38, Núm. 9, pp. 3299-3305

  2. Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC β-lactamase in Acinetobacter baumannii

    Antimicrobial Agents and Chemotherapy, Vol. 44, Núm. 2, pp. 428-432

  3. Molecular characterization of FOX-4, a new AmpC-type plasmid-mediated β-lactamase from an Escherichia coli strain isolated in Spain

    Antimicrobial Agents and Chemotherapy, Vol. 44, Núm. 9, pp. 2549-2553

  4. OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain

    Antimicrobial Agents and Chemotherapy, Vol. 44, Núm. 6, pp. 1556-1561

  5. PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii

    Clinical Microbiology and Infection, Vol. 6, Núm. 12, pp. 635-643

1999

  1. Biochemical and genetic characteristics of TEM-29B, a novel extended spectrum β-lactamase

    FEMS Microbiology Letters, Vol. 174, Núm. 1, pp. 185-190

1982

  1. Ceftazidime: In vitro activity against 3013 clinical isolates

    Chemioterapia, Vol. 1, Núm. 4 Suppl.